Mrv1718007091815552D 19 6 0 0 0 0 999 V2000 -3.7125 2.0072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3000 2.7217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.3000 1.2927 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -4.5375 2.0072 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 1.2375 2.0072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 2.7217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 1.2927 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 0.4125 2.0072 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 5.3625 1.7690 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -3.8500 -1.0717 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.7303 -1.0717 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -1.6107 -1.0717 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -3.8500 -2.7217 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.7303 -2.7217 0.0000 O 0 5 0 0 0 0 0 0 0 0 0 0 -2.8875 0.5782 0.0000 Zn 0 2 0 0 0 0 0 0 0 0 0 0 -5.3625 2.0072 0.0000 Zn 0 2 0 0 0 0 0 0 0 0 0 0 2.0625 0.5782 0.0000 Zn 0 2 0 0 0 0 0 0 0 0 0 0 -0.4125 2.0072 0.0000 Zn 0 2 0 0 0 0 0 0 0 0 0 0 4.5375 1.7690 0.0000 Zn 0 2 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 1 1 0 0 0 0 4 1 1 0 0 0 0 6 5 2 0 0 0 0 7 5 1 0 0 0 0 8 5 1 0 0 0 0 M CHG 8 3 -1 4 -1 7 -1 8 -1 9 -1 10 -1 11 -1 12 -1 M CHG 7 13 -1 14 -1 15 2 16 2 17 2 18 2 19 2 M END > DB14494 > drugbank > [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Zn++].[Zn++].[Zn++].[Zn++].[Zn++].[O-]C([O-])=O.[O-]C([O-])=O > InChI=1S/2CH2O3.6H2O.5Zn/c2*2-1(3)4;;;;;;;;;;;/h2*(H2,2,3,4);6*1H2;;;;;/q;;;;;;;;5*+2/p-10 > UOURRHZRLGCVDA-UHFFFAOYSA-D > C2H6O12Zn5 > 548.96 > 541.631636 > 3 > 25 > 3.5154552300033055 > 1 > 0 > 0 > 0 > pentazinc(2+) hexahydroxide dicarbonate > 0.32 > 0.25005136566666664 > -0.36 > 0 > 0 > -1 > 10.638414228618222 > 6.052541895520343 > 63.19 > 31.172400000000003 > 0 > 0 > 1.09e+02 g/l > pentazinc(2+) hexahydroxide dicarbonate > 0 > DB14494 > experimental > Zinc carbonate > Basic zinc carbonate; Zinc carbonate; Zinc carbonate, basic; Zinc subcarbonate > Go PSP calamine; Ma Ying Long Hemorrhoidal; PSP Calamine $$$$